表紙
市場調查報告書

全球醫藥品研究製造業務受託(CRAM)市場:2020年∼2024年的預測

Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 825223
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
全球醫藥品研究製造業務受託(CRAM)市場:2020年∼2024年的預測 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2020-2024
出版日期: 2020年03月06日內容資訊: 英文 120 Pages
簡介

全球醫藥品研究製造業務受託(CRAM)市場在預測期間內,預計將以9%的年複合成長率增長,2024年達到690億9,000萬美元。市場成長的主要因素有新興市場中具有成本效益的原材料。此外專注於核心競爭力的需求不斷增長,預計將在預測期內推動市場增長。

本報告提供全球醫藥品研究製造業務受託(CRAM)市場的相關調查,提供市場趨勢和課題,成長要素,各服務·各地區的市場分析,業者情勢,主要企業的簡介等資訊。

目錄

摘要整理

市場預測

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2019年
  • 市場預測:2019-2024年的預測

波特的五力分析

客戶形勢

  • 概要

地區形勢

  • 市場區隔
  • 比較
  • 北美
  • 亞太地區
  • 歐洲
  • 其他地區
  • 主要國家
  • 市場機會

市場成長要素,課題,及趨勢

  • 市場成長要素
  • 交易量的成長要素:需求主導的成長
  • 交易量的成長要素:供給主導的成長
  • 交易量的成長要素:外部要素
  • 交易量的成長要素-需求轉移到鄰近市場
  • 價格成長要素:通貨膨脹
  • 價格成長要素-從低價格單位轉變到高價格單位
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 形勢的創新
  • 供應商分析

企業簡介

  • 供應商的市場上地位
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Catalent Inc.
  • Dr. Reddy's Laboratories Ltd.
  • ICON Plc
  • IQVIA Holding Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group Ltd.
  • PRA Health Sciences Inc.
  • Thermo Fisher Scientific Inc.

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR41601

Technavio has been monitoring the global pharmaceutical contract research and manufacturing (cram) market 2020-2024 and it is poised to grow by USD 69.09 bn during 2020-2024, progressing at a CAGR of 9% during the forecast period. Our reports on global pharmaceutical contract research and manufacturing (cram) market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by availability of cost-efficient resources in emerging markets. In addition, growing need to focus on core competencies is anticipated to boost the growth of the global pharmaceutical contract research and manufacturing (cram) market 2020-2024 as well.

Market Segmentation

Technavio's ‘global pharmaceutical contract research and manufacturing (cram) market 2020-2024’ is segmented as below:

Service:

  • CMO
  • CRO

Geographic segmentation

  • North America
  • APAC
  • Europe
  • ROW

Key Trends for global pharmaceutical contract research and manufacturing (cram) market 2020-2024 growth

This study identifies growing need to focus on core competencies as the prime reasons driving the global pharmaceutical contract research and manufacturing (cram) market 2020-2024 growth during the next few years.

Prominent vendors in global pharmaceutical contract research and manufacturing (cram) market 2020-2024

We provide a detailed analysis of around 25 vendors operating in the global pharmaceutical contract research and manufacturing (cram) market 2020-2024, including some of the vendors such as Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Catalent Inc., Dr. Reddy's Laboratories Ltd., ICON Plc, IQVIA Holding Inc., Laboratory Corporation of America Holdings, Lonza Group Ltd., PRA Health Sciences Inc. and Thermo Fisher Scientific Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption
  • Vendor Analysis

Vendors covered

  • Market positioning of vendors
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Catalent Inc.
  • Dr. Reddy's Laboratories Ltd.
  • ICON Plc
  • IQVIA Holding Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group Ltd.
  • PRA Health Sciences Inc.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Market in focus
  • 8.Parent market
  • 9.Market characteristics
  • 10.Product / Service portfolio of key vendors included in the market definition
  • 11.Market segments
  • 12.Global - Market size and forecast 2019 - 2024 ($ billion)
  • 13.Global market: Year-over-year growth 2019 - 2024 (%)
  • 14.Five forces analysis 2019 & 2024
  • 15.Bargaining power of buyers
  • 16.Bargaining power of suppliers
  • 17.Threat of new entrants
  • 18.Threat of substitutes
  • 19.Threat of rivalry
  • 20.Market condition - Five forces 2019
  • 21.Customer landscape
  • 22.Market share by geography 2019-2024 (%)
  • 23.Geographic comparison
  • 24.North America - Market size and forecast 2019-2024 ($ billion)
  • 25.North America - Year-over-year growth 2019-2024 (%)
  • 26.APAC - Market size and forecast 2019-2024 ($ billion)
  • 27.APAC - Year-over-year growth 2019-2024 (%)
  • 28.Europe - Market size and forecast 2019-2024 ($ billion)
  • 29.Europe - Year-over-year growth 2019-2024 (%)
  • 30.ROW - Market size and forecast 2019-2024 ($ billion)
  • 31.ROW - Year-over-year growth 2019-2024 (%)
  • 32.Key leading countries
  • 33.Market opportunity by geography ($ billion)
  • 34.Impact of drivers and challenges
  • 35.Vendor landscape
  • 36.Landscape disruption
  • 37.Industry risks
  • 38.Vendors covered
  • 39.Market positioning of vendors
  • 40.Boehringer Ingelheim International GmbH - Overview
  • 41.Boehringer Ingelheim International GmbH - Business segments
  • 42.Boehringer Ingelheim International GmbH - Key offerings
  • 43.Boehringer Ingelheim International GmbH - Key customers
  • 44.Boehringer Ingelheim International GmbH - Segment focus
  • 45.Cadila Healthcare Ltd. - Overview
  • 46.Cadila Healthcare Ltd. - Business segments
  • 47.Cadila Healthcare Ltd. - Key offerings
  • 48.Cadila Healthcare Ltd. - Key customers
  • 49.Cadila Healthcare Ltd. - Segment focus
  • 50.Catalent Inc. - Overview
  • 51.Catalent Inc. - Business segments
  • 52.Catalent Inc. - Key offerings
  • 53.Catalent Inc. - Key customers
  • 54.Catalent Inc. - Segment focus
  • 55.Dr. Reddy's Laboratories Ltd. - Overview
  • 56.Dr. Reddy's Laboratories Ltd. - Business segments
  • 57.Dr. Reddy's Laboratories Ltd. - Key offerings
  • 58.Dr. Reddy's Laboratories Ltd. - Key customers
  • 59.Dr. Reddy's Laboratories Ltd. - Segment focus
  • 60.ICON Plc - Overview
  • 61.ICON Plc - Business segments
  • 62.ICON Plc - Key offerings
  • 63.ICON Plc - Key customers
  • 64.ICON Plc - Segment focus
  • 65.IQVIA Holding Inc. - Overview
  • 66.IQVIA Holding Inc. - Business segments
  • 67.IQVIA Holding Inc. - Key offerings
  • 68.IQVIA Holding Inc. - Key customers
  • 69.IQVIA Holding Inc. - Segment focus
  • 70.Laboratory Corporation of America Holdings - Overview
  • 71.Laboratory Corporation of America Holdings - Business segments
  • 72.Laboratory Corporation of America Holdings - Key offerings
  • 73.Laboratory Corporation of America Holdings - Key customers
  • 74.Laboratory Corporation of America Holdings - Segment focus
  • 75.Lonza Group Ltd. - Overview
  • 76.Lonza Group Ltd. - Business segments
  • 77.Lonza Group Ltd. - Key offerings
  • 78.Lonza Group Ltd. - Key customers
  • 79.Lonza Group Ltd. - Segment focus
  • 80.PRA Health Sciences Inc. - Overview
  • 81.PRA Health Sciences Inc. - Business segments
  • 82.PRA Health Sciences Inc. - Key offerings
  • 83.PRA Health Sciences Inc. - Key customers
  • 84.PRA Health Sciences Inc. - Segment focus
  • 85.Thermo Fisher Scientific Inc. - Overview
  • 86.Thermo Fisher Scientific Inc. - Business segments
  • 87.Thermo Fisher Scientific Inc. - Key offerings
  • 88.Thermo Fisher Scientific Inc. - Key customers
  • 89.Thermo Fisher Scientific Inc. - Segment focus
  • 90.Currency conversion rates for US$
  • 91.Research Methodology
  • 92.Validation techniques employed for market sizing
  • 93.Information sources
  • 94.List of abbreviations